Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their Parents

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cough is a frequent symptom in children and infants and is one of the most common reasons parents visit a healthcare provider for their child. The US Food and Drug Administration has issued a warning that over-the-counter cough and cold medicines including antihistamines, decongestants, anti-tussives, and expectorants should not be administered to children younger than 2 years of age due not only to lack of proven efficacy, but also because of important safety concerns. Honey, another method of soothing cough cannot be used in children \<1 year due to concerns for infantile botulism. A preparation from agave syrup has been created to address the need for an infant cough syrup. Although no studies have formally evaluated the use of agave nectar for nocturnal cough associated with Upper Respiratory Infections, the demulcent effect and sweet taste of agave nectar may provide some relief from cough in children.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Novel Formulation of Pasteurized Maple Cough Syrup Compared With Placebo on Nocturnal Cough and Sleep Quality in Infants With Upper Respiratory Infection

NCT01588249

Cough Upper Respiratory Infection Nocturnal Cough

TERMINATED NA

Efficacy & Tolerability of a Specific Plantain,Thyme and Honey Cough Syrup vs Placebo in Child Cough Due to Common Cold

NCT02486835

Cough

COMPLETED NA

Comparison of a Protective Cough Syrup Against Placebo on Night Cough in Children 1-5 Years Coughing Since 1- 2 Days Due to Common Cold

NCT03218696

Cough Acute Upper Respiratory Tract Infection

UNKNOWN NA

Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep

NCT00127686

Cough Respiratory Tract Infections

COMPLETED PHASE1

Promoting Safe Use of Children's Cough/Cold Medicines

NCT03126851

Cough

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cough

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Colored, Flavored water

The placebo will be colored to approximate the reddish amber color of the agave syrup. The placebo will use the same flavoring used in the agave syrup. The placebo will be created in a GMP facility

Group Type PLACEBO_COMPARATOR

Agave Syrup

Intervention Type DIETARY_SUPPLEMENT

Agave Syrup

The formulation of pasteurized agave syrup consists of pasteurized agave syrup and natural flavoring.

Group Type EXPERIMENTAL

Agave Syrup

Intervention Type DIETARY_SUPPLEMENT

Air-filled oral syringe

Air-filled oral syringe to match experimental and placebo arm

Group Type SHAM_COMPARATOR

Agave Syrup

Intervention Type DIETARY_SUPPLEMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Agave Syrup

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Zarbee's Naturals Agave Baby Cough Syrup

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Otherwise healthy male or female infant who is 2 to \<48 months of age.
* presents with a non-specific acute cough for 7 or fewer days' duration.
* Parents/legal authorized representative reporting at least moderate cough and cold symptoms.
* Parent/legal authorized representative was in the home with the child on the night prior to enrollment and plans to be in the home with the child on the night when study treatment will be administered
* Parent/legal authorized representative who is willing and able to comply with study requirements.

Exclusion Criteria

* Previous participation in this clinical trial
* Gestational age at birth \<35 weeks.
* Signs or symptoms of a more treatable disease (eg, asthma, pneumonia, laryngotracheobronchitis, sinusitis, allergic rhinitis).
* Diagnosis of influenza, bronchiolitis or respiratory syncytial virus (RSV).
* History of reactive airways disease, asthma, or chronic lung disease.
* Use of any medication or honey to treat cough within 6 hours of bedtime on the evening prior to or on the day of enrollment.
* Presence of any significant disease including immunodeficiency, hepatic, renal,cardiovascular, or hematologic disease or any other health condition that, in the opinion of the investigator, would preclude participation in the study.
* Known allergy to agave nectar or grape flavoring

Minimum Eligible Age

2 Months

Maximum Eligible Age

48 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No